A Study of Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy
PHASE3
The study is being conducted to evaluate the tolerability, safety and effic...
A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based Chemotherapy
PHASE3
This is a multicenter, randomized, blinded, 3-arm Phase 3 study to evaluate...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
PHASE3
To evaluate whether Fuzuloparib plus AA-P is superior to placebo plus AA-P ...